Efficacy and Safety of Medium-to-long-term Use of Tolterodine Extended Release with or without Tamsulosin in Patients with Benign Prostate Hyperplasia and Larger Prostate Size: A Double-blind, Placebo-controlled, Randomized Clinical Trial
Background: The medium-to-long-term use of antimuscarinics alone or in combination with an α-blocker in men with an enlarged prostate is still controversial. This double-blind, placebo-controlled, randomized clinical trial aimed to investigate the efficacy and safety of medium-to-long-term use of to...
Main Authors: | Jian-Liang Cai, Zhe Zhou, Yan Yang, Yi-Fu Yan, Shuo Jing, Yan-Qun Na |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2016-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=24;spage=2899;epage=2906;aulast=Cai |
Similar Items
-
The effect of extended release tolterodine used for overactive bladder treatment on female sexual function
by: Athanasios Zachariou, et al. -
Comparative in vitro assessment of tolterodine tartrate tablets by high performance liquid chromatographic (HPLC)
by: Hossein Danafar
Published: (2016-06-01) -
Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation
by: Rajabalaya Rajan, et al.
Published: (2017-09-01) -
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
by: Danny Ulahannan, et al.
Published: (2009-04-01) -
To compare the efficacy of tamsulosin and tolterodine in double-J stent-related symptoms: A prospective randomized trial
by: Abhay Mahajan, et al.
Published: (2019-01-01)